Alkeus Pharmaceuticals, Inc. vs Rznomics Inc.

Alkeus Pharmaceuticals, Inc. logo

Alkeus Pharmaceuticals, Inc.

Transformation in Sight

58 employees · est. 2010

VS
Rznomics Inc. logo

Rznomics Inc.

Development of innovative treatments for cancer & intractable diseases through the RNA-based platform technology

11 employees · est. 2017 · Korea South

Alkeus Pharmaceuticals, Inc. is the older company (2010 vs 2017); Alkeus Pharmaceuticals, Inc. is the larger of the two.

Side-by-Side Comparison

Alkeus Pharmaceuticals, Inc. Rznomics Inc.
Founded
2010 older 2017
Headquarters
Not tracked yet Korea South
Employees
58 larger 11
Industry
Biotechnology, Medical Devices, Pharmaceutical Biopharma, Biotechnology
Funding Stage
Series B Series C
Total Funding
$150.10M $59.70B
Funding Rounds
2 3
Taxonomy
BiopharmaceuticalLate-stage DevelopmentTherapeuticsEye DiseasesStargardt DiseaseGeographic Atrophy +4 BiopharmaceuticalsRNA-based Platform TechnologyOncologyGenetic DiseaseTrans-splicing RibozymeClinical Trials +8
Website
alkeuspharma.com rznomics.com
Alkeus Pharmaceuticals, Inc. logo

About Alkeus Pharmaceuticals, Inc.

Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company in the Biotechnology and Pharmaceutical industries. The company, founded in 2011, is focused on developing transformative therapeutics for serious, progressive eye diseases leading to blindness. Their lead compound, ALK-001, an o...

Rznomics Inc. logo

About Rznomics Inc.

Rznomics Inc. is a biopharmaceutical startup focused on developing innovative treatments for cancer and intractable diseases through its RNA-based platform technology called trans-splicing ribozyme. Established in 2017, Rznomics has gained recognition from bio-focused institutions and successfully r...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Alkeus Pharmaceuticals, Inc. and Rznomics Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Alkeus Pharmaceuticals, Inc. or Rznomics Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Alkeus Pharmaceuticals, Inc. was founded in 2010, with 58 employees. Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company in the Biotechnology and Pharmaceutical industries. The company, founded in 2011, is focused on developing transformative therape. Rznomics Inc. was founded in 2017, based in Korea South, with 11 employees. Rznomics Inc. is a biopharmaceutical startup focused on developing innovative treatments for cancer and intractable diseases through its RNA-based platform technology called trans-splicing ribozyme. E.
Alkeus Pharmaceuticals, Inc. has raised $150.10M and Rznomics Inc. $59.70B. Latest stage: Alkeus Pharmaceuticals, Inc. Series B, Rznomics Inc. Series C.
Both work in Biotechnology.

Compare Alkeus Pharmaceuticals, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Alkeus Pharmaceuticals, Inc. on 12 Sep 2024, and Rznomics Inc. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes